TIAM1驱动前列腺分支表型,是良性前列腺增生症的潜在治疗标
Hamed Khedmatgozar1, Sayanika Dutta1, Michael Dominguez1
1Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, United States of America.
JCI insight
|May 20, 2025
概括
研究人员发现,TIAM1 (T淋巴瘤入侵和转移诱导蛋白-1) 通过促进前列腺芽和分支,驱动良性前列腺激增 (BPH) 的生长. 用NSC23766抑制TIAM1-RAC1信号传递为BPH提供了一个潜在的新疗法.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 良性前列腺增生 (BPH) 是老年男性中普遍存在的疾病.
- BPH涉及到像前列腺芽和分支这样的发育过程的重新激活.
- 精确的BPH复激活的分子驱动因素尚未完全理解.
研究的目的:
- 在BPH中确定前列腺芽和分支的关键分子调节者.
- 根据已识别的分子途径,探索BPH的潜在治疗点.
主要方法:
- 从患者数据生成了BPH的公正的转录组签名.
- 利用人类前列腺细胞系衍生器官培养物用于功能性检测.
- 研究了TIAM1及其信号通路 (TIAM1-RAC1) 的作用.
- 在BPH模型中测试了TIAM1-RAC1抑制剂NSC23766的疗效.
主要成果:
- 确定TIAM1在BPH中显著上调,对于前列腺芽生长和分支是必不可少的.
- 证明了TIAM1的遗传淘汰减少了有机体分支.
- 表明NSC23766有效抑制TIAM1-RAC1信号传递,并减少前列腺器官分支.
- 在用NSC23766治疗的患者衍生BPH器官中观察到增长抑制,证实了翻译相关性.
结论:
- TIAM1是BPH前列腺分支和生长的关键调节者.
- 准TIAM1-RAC1信号通路代表了管理BPH的有希望的治疗策略.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K


